Clinical trial
A Prospective, Controlled, Randomized, Multi-Center, Pivotal Study Evaluating the Safety and Efficacy of AdhexilTM in Prevention And/Or Reduction of Adhesions in Gynecology Surgery
NCT00865488 is registered in ClinicalTrials.gov with OMRIX Biopharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Prospective, Controlled, Randomized, Multi-Center, Pivotal Study Evaluating the Safety and Efficacy of AdhexilTM in Prevention And/Or Reduction of Adhesions in Gynecology Surgery
- Lead sponsor
- OMRIX Biopharmaceuticals
- Phase
- Phase 3
- Overall status
- Suspended
- Start date
- May 31, 2009
- Completion date
- April 30, 2010
- Enrollment
- 80 (estimated)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
adhesions, endometriosis, ovarian cysts